Mississippi 2022 Regular Session

Mississippi House Bill HB681

Introduced
1/17/22  
Refer
1/17/22  
Engrossed
2/3/22  
Refer
2/11/22  

Caption

Kratom; include in Schedule I controlled substances list.

Impact

The addition of kratom to Schedule I is expected to significantly alter the landscape of drug policy in Mississippi. Supporters of the bill argue that this step is necessary due to concerns about the potential risks associated with kratom use, such as addiction and other health issues. By regulating kratom similarly to traditional narcotics, the legislation aims to protect public health and minimize the societal impacts of its misuse. However, this move also raises issues regarding access for individuals who advocate for the benefits of kratom, such as its use for pain relief and managing anxiety.

Summary

House Bill 681 aims to amend Section 41-29-113 of the Mississippi Code of 1972 to include kratom in Schedule I of the Uniform Controlled Substances Act. By adding kratom to this classification, the bill seeks to impose stricter regulations on its availability and distribution within the state. As a result, the possession, sale, or distribution of kratom could lead to legal repercussions, aligning it with other substances deemed high-risk and potentially harmful to public health.

Sentiment

Sentiment surrounding HB 681 appears to be divisive. Proponents emphasize the importance of regulating substances that may pose significant health risks, while opponents highlight the potential loss of access to a natural substance that some users claim helps with various health conditions. This dichotomy reflects broader ongoing debates about drug regulation, personal choice, and community health priorities, with strong opinions on both ends regarding the effectiveness and consequences of prohibitionist measures in drug policy.

Contention

Notable points of contention within discussions of the bill focus on the efficacy of including kratom in Schedule I, especially considering the lack of comprehensive scientific studies proving its harm. Advocacy groups have raised concerns that this legislative action could lead to criminalizing consumers who use kratom responsibly and safely. Additionally, some have argued that it undermines local autonomy in managing public health concerns, potentially leading to increased underground markets and implications for law enforcement resources.

Companion Bills

No companion bills found.

Similar Bills

MS HB4

Tianeptine; include in Schedule I controlled substance list.

MS HB5

Kratom; include in Schedule I controlled substances list.

MS HB364

Kratom and Tianeptine; include in Schedule I controlled substances list.

MS HB1086

Tianeptine; add to list of Schedule I controlled substances.

MS HB663

Kratom; include in Schedule I of the Uniform Controlled Substances Act.

MS HB1502

MS Hemp Cultivation Act; revise provisions of and legalize manufacture and sale of hemp beverages.

MS SB2187

Uniform Controlled Substances Law; revise Schedule I to include certain hemp products.

MS SB2314

Uniform Controlled Substances Law; include certain hemp products on Schedule I.